Luis Bernardo Enríquez Sánchez

Dr. Luis Bernardo Enríquez Sánchez


Research Focus & Metrics

Academic Career Length

9Years (2018-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 July 2022 in Revista de Gastroenterología de México
Verified
Journal Article
Open access
LSLuis Bernardo Enríquez Sánchez
Luis Bernardo Enríquez Sánchez
LGL.G. Gallegos-Portillo
L.G. Gallegos-Portillo
JCJ. Camarillo-Cisneros
J. Camarillo-Cisneros
MCM. Cisneros-Castolo
M. Cisneros-Castolo
JMJ.J. Montelongo-Santiesteban
J.J. Montelongo-Santiesteban
ACA.E. Contreras-Pacheco
A.E. Contreras-Pacheco
Helicobacter pylori (H. pylori) is known to be capable of causing chronic inflammation of the gastric mucosa that slowly progresses through the premalignant stages, reaching localized gastric adenocarcinoma (GAC). Its outcome is closely related to the stage at which diagnosis is made. The aim of the present study was to determine cost-benefit by comparing esophagogastroduodenoscopy, serum pepsinogen detection, and no screening at all. Utilizing Markov chains and Monte Carlo simulation, the costs and effects of various detection modalities were simulated to analyze the cost-benefit of each strategy. For our population, we used the published data of patients with gastric cancer, applicable to the Mexican population. The results were reported as incremental cost-effectiveness ratios. The best strategy was serum pepsinogen determination, followed by the strategy of endoscopic examination with continued monitoring every 3 years. The performance of serum pepsinogen serology and directed endoscopic examination (and continued monitoring, if necessary) for GAC screening could be a cost-effective intervention in Mexico, despite the low-to-moderate general prevalence of the disease.

27 June 2024 in Horizonte Médico (Lima)
Verified
Journal Article
Open access
PDF file
DCDepartamento de Cirugía. Chihuahua Hospital Central del Estado de Chihuahua
Departamento de Cirugía. Chihuahua Hospital Central del Estado de Chihuahua
MRManuel David Pérez Ruiz
Manuel David Pérez Ruiz
LSLuis Bernardo Enríquez Sánchez
Luis Bernardo Enríquez Sánchez
CLCarolina Martínez Loya
Carolina Martínez Loya
MPMiguel Eduardo Pacheco Pérez
Miguel Eduardo Pacheco Pérez
CGCarlos Eduardo Quiñones Gutiérrez
Carlos Eduardo Quiñones Gutiérrez
Objetivo: Determinar los tiempos quirúrgicos estándar de los cuatro procedimientos más comunes en cirugía general (hernioplastia inguinal unilateral, hernioplastia inguinal bilateral, hernioplastia umbilical y colecistectomía) de un hospital de segundo nivel y calcular la probabilidad de extensión de cada uno de los procedimientos. La eficiencia es un fenómeno ampliamente estudiado en el ámbito económico, pues hace referencia a la necesidad de menor cantidad de factores para la producción de un determinado nivel de bienes y servicios, por ello, es de vital importancia incluirlo en el ámbito quirúrgico. Materiales y métodos: Estudio observacional, descriptivo y retrospectivo. Se utilizaron los registros de quirófano de un hospital de segundo nivel del año 2017 al 2019 del servicio de Cirugía General. A partir de esta información, se estandarizó el tiempo necesario para cada procedimiento mediante la media de cada uno (hernioplastia umbilical, hernioplastia inguinal unilateral o bilateral y colecistectomía). Se calculó la probabilidad de extensión de las cirugías tomando en consideración los datos obtenidos y el intervalo de confianza. Resultados: Para el procedimiento de hernioplastia inguinal unilateral se obtuvo una media de 76 min (IC 95,00 %: 72-80 min, DE 23); en hernioplastia inguinal bilateral, una media de 104,38 min (IC 95,00 %: 91-116 min, DE 41,7); en hernioplastia umbilical, una media de 59,31 min (IC 95,00 %: 54-63 min, DE 29,9), y en colecistectomía, una media de 85,735 min (IC 95,00 %: 83-88 min). La probabilidad de que se programen tres cirugías y todas estén a tiempo (límite superior del IC) es de 92,69 %, la probabilidad de que se programen tres cirugías y todas se prolonguen es de 0,0016 % (límite inferior del IC). Conclusiones: Es posible realizar la planeación de las cirugías programadas mediante el uso de tiempos quirúrgicos estandarizados. Se requiere contar con estadística actualizada de los procedimientos quirúrgicos (promedios del tiempo de realización de cada procedimiento), ya que es posible detectar y supervisar de manera más precisa la dinámica de quirófano mediante la detección de las áreas de oportunidad, de esta manera, se eficientizará el tiempo de quirófano para beneficio de los sistemas de salud y los pacientes.

5 August 2019 in Cirugía y Cirujanos
Verified
Journal Article
Closed access
LSLuis Bernardo Enríquez Sánchez
Luis Bernardo Enríquez Sánchez
MCMarco J. Carrillo-Gorena
Marco J. Carrillo-Gorena
LGLaura A. Granados-Aldaz
Laura A. Granados-Aldaz
LBLuis F. Balderrama-Miramontes
Luis F. Balderrama-Miramontes
LGLuis G. Gallegos-Portillo
Luis G. Gallegos-Portillo
KFKarla Fernández-Villalobos
Karla Fernández-Villalobos
Background: Intestinal failure (IF) was first defined as "a reduction in the functioning gut mass below the minimal amount necessary for adequate digestion and absorption." In our environment, there are no statistical data for IF in adult patients' extended length of stay (LOS), nor the economic impact that it implies. Objective: The objective of the study was to describe the association between the IF type and extended LOS. Methods: Patients admitted to our IF Unit between March 2016 and March 2018 were enrolled. We conducted a 2-year retrospective cross-sectional study. Results: From the total of 53 patients, 35% corresponded to type I IF, 58.5% to type II IF, and 7.5% to type III IF. The mean LOS, according to the type of functional IF was 51 days for type I, 7748 days for type II, and 68.25 days for type III. The mean LOS for the three IF types was 67.79 days. Conclusion: Extended LOS occurs in an important proportion of patients with IF, resulting in increased morbidity and mortality, as well as in costs and associated side effects. Future research should focus on economic studies, to know the economic impact that this subject entails for our health systems.

1 July 2022 in Revista de Gastroenterología de México (English Edition)
Verified
Journal Article
Open access
LSLuis Bernardo Enríquez Sánchez
Luis Bernardo Enríquez Sánchez
LGL.G. Gallegos-Portillo
L.G. Gallegos-Portillo
JCJ. Camarillo-Cisneros
J. Camarillo-Cisneros
MCM. Cisneros-Castolo
M. Cisneros-Castolo
JMJ.J. Montelongo-Santiesteban
J.J. Montelongo-Santiesteban
ACA.E. Contreras-Pacheco
A.E. Contreras-Pacheco
Helicobacter pylori (H. pylori) is known to be capable of causing chronic inflammation of the gastric mucosa that slowly progresses through the premalignant stages, reaching localized gastric adenocarcinoma (GAC). Its outcome is closely related to the stage at which diagnosis is made. The aim of the present study was to determine cost-benefit by comparing esophagogastroduodenoscopy, serum pepsinogen detection, and no screening at all. Utilizing Markov chains and Monte Carlo simulation, the costs and effects of various detection modalities were simulated to analyze the cost-benefit of each strategy. For our population, we used the published data of patients with gastric cancer, applicable to the Mexican population. The results were reported as incremental cost-effectiveness ratios. The best strategy was serum pepsinogen determination, followed by the strategy of endoscopic examination with continued monitoring every 3 years. The performance of serum pepsinogen serology and directed endoscopic examination (and continued monitoring, if necessary) for GAC screening could be a cost-effective intervention in Mexico, despite the low-to-moderate general prevalence of the disease.

2 January 2023 in Salud Pública de México
Verified
Journal Article
Open access
PDF file
MSMaría Isabel Saad-Manzanera
María Isabel Saad-Manzanera
JHJesús Alan Hernández-Galván
Jesús Alan Hernández-Galván
SGSofía Carolina González-Cristóbal
Sofía Carolina González-Cristóbal
EVEliden Vázquez-Torres
Eliden Vázquez-Torres
Graciela Ramírez-AlonsoGraciela Ramírez-Alonso
Graciela Ramírez-Alonso
LSLuis Bernardo Enríquez Sánchez
Luis Bernardo Enríquez Sánchez
No-fever, no-cough, no-fatigue Fever, cough, fatigue, cough with fatigue Fever with cough, fever with fatigue n progression/exposed (%) 23/914 (2) 66/615 (10.7) 31/106 (29) Days to progression 8 (5.5-9.5) 7 (5-9) 6 (4-7.5) Risk factors Male No 11/572 (2) 31/356 (9) 17/55 (31) Yes 12/342 (4) 35/259 (14) 14/51 (27)

1 January 2020 in Cirujano General
Verified
Journal Article
Open access
PDF file
LSLuis Bernardo Enríquez Sánchez
Luis Bernardo Enríquez Sánchez
MCMarco Javier Carrillo-Gorena
Marco Javier Carrillo-Gorena
KFKarla Fernández-Villalobos
Karla Fernández-Villalobos
LGLaura Andrea Granados-Aldaz
Laura Andrea Granados-Aldaz
LBLuis Fernando Balderrama-Miramontes
Luis Fernando Balderrama-Miramontes
AGAbisag González-Villa
Abisag González-Villa